Ardx marketwatch.

ARDX Earnings Date and Information. Ardelyx last issued its quarterly earnings data on May 2nd, 2024. The biopharmaceutical company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.02. The business earned $46 million during the quarter, compared to analysts' expectations of $36.40 million.$-0.29. Market Cap. $1.88 B. Shares Outstanding. 233.98 M. Public Float. 225.15 M. Yield. ARDX is not currently paying a regular dividend. Latest Dividend. N/A. Ex-Dividend Date. N/A. ? Short...View Ardelyx, Inc. ARDX stock quote prices, financial information, real-time forecasts, and company news from CNN.Ardelyx Inc. company facts, information and financial ratios from MarketWatch.

Ardelyx Inc. company facts, information and financial ratios from MarketWatch.

ARDX Strong upgrade from a top financial firm ARDX Ardelyx is a biopharmaceutical company that discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the US and internationally. On 3/2/2022 Jefferies Financial Group Upgraded ARDX from Hold to Buy raising the price target from $1.00 to $.

Ardelyx, Inc. Reports Employment Inducement Grants. WALTHAM, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on December 18, 2023 ...Ardelyx Inc. company facts, information and financial ratios from MarketWatch.Ardelyx Inc. company facts, information and financial ratios from MarketWatch.CL.1 | A complete Crude Oil WTI (NYM $/bbl) Front Month futures overview by MarketWatch. View the futures and commodity market news, futures pricing and futures trading.3.16 to 10.13. News | Industry | Market Advisers | Analysts | SEC Filings | Insiders | Annual Report | Profile. Create Alert | Go to Watchlist | Technical Analysis. email this chart printer-friendly format. ARDX - Ardelyx Inc. Advanced Chart, Quote and financial news from the leading provider and award-winning BigCharts.com.

2 days ago · New York Community Bancorp Inc. $4.06. 1.89M. 0.17. 4.36%. Monitor leaders, laggards and most active stocks during after-market hours trading.

May 6, 2024 · After-Hours Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as ...

Ardelyx Inc. SEC filings breakout by MarketWatch. View the ARDX U.S. Securities and Exchange Commission reporting information.6 days ago · See the latest Ardelyx Inc stock price (ARDX:XNAS), related news, valuation, ... MarketWatch Sep 25, 2023 12:06pm. Trading Information . Previous Close Price $8.06. Day Range. Ardelyx Inc. company facts, information and financial ratios from MarketWatch. Ardelyx Inc. company facts, information and financial ratios from MarketWatch.Olive Garden is bringing back its Never Ending Pasta Pass this year for the fifth time. The offer now comes with an annual option that enables you to get all the spaghetti and meat...Get Ardelyx Inc (ARDX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

Ardelyx Inc. company facts, information and financial ratios from MarketWatch.$-0.29. Market Cap. $1.88 B. Shares Outstanding. 233.98 M. Public Float. 225.15 M. Yield. ARDX is not currently paying a regular dividend. Latest Dividend. N/A. Ex-Dividend Date. N/A. ? Short...Nov 17, 2022 · Shares of Ardelyx Inc. rocketed 75.4% on heavy volume toward a 16-month high in premarket trading Thursday, after an advisory panel of the U.S. Food and Drug Administration voted that benefits of ... Stay Informed on ARDX's Latest After Hours Trades. Get the most current trading insights on Ardelyx, Inc. Common Stock (ARDX) with Nasdaq.Ardelyx, Inc. Reports Employment Inducement Grants. WALTHAM, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on December 18, 2023 ...Ardelyx Inc. company facts, information and financial ratios from MarketWatch.

ARDX Earnings Date and Information. Ardelyx last issued its quarterly earnings data on May 2nd, 2024. The biopharmaceutical company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.02. The business earned $46 million during the quarter, compared to analysts' expectations of $36.40 million.ARDX Strong upgrade from a top financial firm ARDX Ardelyx is a biopharmaceutical company that discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the US and internationally. On 3/2/2022 Jefferies Financial Group Upgraded ARDX from Hold to Buy raising the price target from $1.00 to $.

4.46. 4.46. 4,816,400. Related Tickers. Discover historical prices for ARDX stock on Yahoo Finance. View daily, weekly or monthly format back to when Ardelyx, Inc. stock was issued.While Ardelyx, Inc. (NASDAQ:ARDX) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 23% in the last quarter. While that's ...ARDX. -4.95%. Shares in Ardelyx Inc. plummeted more than 70% in after-hours trading Monday, following the biopharmaceutical company's announcement that the Food and Drug Administration appears ...Q1 net loss was $26.8 million, but Ardelyx raised $51.9 million through sales of their common stock at an average price of about $3.35, leaving $130.4 million in total cash and investments as of ...Ardelyx Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time ARDX stock price.Ardelyx Inc. (ARDX) on Tuesday won its long fight for U.S. regulatory approval of a treatment designed to help patients with chronic kidney disease. The biopharma company said late Tuesday that ...Ardelyx Inc. Quarterly stock financials by MarketWatch. View the latest ARDX financial statements, income statements and financial ratios.

6 days ago · About ARDX. Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor for the treatment of patients with irritable bowel syndrome with constipation.

Palatin Technologies Inc. 2.93%. $34.05M. Corcept Therapeutics Inc. -2.15%. $2.55B. AVXL | Complete Anavex Life Sciences Corp. stock news by MarketWatch. View real-time stock prices and stock ...

Ardelyx Inc. company facts, information and financial ratios from MarketWatch.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.SPX | A complete S&P 500 Index index overview by MarketWatch. View stock market news, stock market data and trading information.ARDX | Complete Ardelyx Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Get the latest Ardelyx Inc (ARDX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Ardelyx Inc. Quarterly cash flow by MarketWatch. View ARDX net cash flow, operating cash flow, operating expenses and cash dividends. Last Updated: Apr 10, 2024 2:23 p.m. CST Delayed quote. $ 113.80. -26.20 -18.71%. Previous Close. $140.00. Ardelyx Inc. advanced stock charts by MarketWatch. View ARDX historial stock data and ...ARDX stock closed at $5.91 and is up $0.24 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ARDX has a strong overall score of 86 meaning the stock holds a better value than 86% of stocks at its current price. InvestorsObserver's ...

ARDX - Ardelyx Inc. Chart, Quote and financial news from the leading provider and award-winning BigCharts.com.Ardelyx Inc. company facts, information and financial ratios from MarketWatch.Real time Ardelyx (ARDX) stock price quote, stock graph, news & analysis.Instagram:https://instagram. honda hrv recallsclean eatz wilmingtonicici bank limited swift codetrulieve squirrel hill Oct 17, 2023 · Ardelyx Inc. ARDX, +0.62% on Tuesday won its long fight for U.S. regulatory approval of a treatment designed to help patients with chronic kidney disease. The biopharma company said late Tuesday ... Ardelyx Inc. company facts, information and financial ratios from MarketWatch. stone fire pasadena100 grams equal to how many cups VERU | Complete Veru Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.View today's Ardelyx Inc stock price and latest ARDX news and analysis. Create real-time notifications to follow any changes in the live stock price. under deck lattice ideas Ardelyx Inc. SEC filings breakout by MarketWatch. View the ARDX U.S. Securities and Exchange Commission reporting information.(RTTNews) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.05 A.M. ET). In the Green Bullfrog A... (RTTNews) - The following are ...View the latest Ardelyx Inc. (ARDX) stock price, news, historical charts, analyst ratings and financial information from WSJ.